Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study
- Authors
- Choi, Kwan Woo; Jang, Eun Hye; Kim, Ah Young; Fava, Maurizio; Mischoulon, David; Papakostas, George I.; Kim, Dong Jun; Kim, Kiwon; Yu, Han Young; Jeon, Hong Jin
- Issue Date
- Mar-2019
- Publisher
- Elsevier BV
- Keywords
- Heart rate variability; Major depression disorder; Panic disorder; pNN50; LF/HF ratio; Treatment response
- Citation
- Journal of Affective Disorders, v.246, pp 157 - 165
- Pages
- 9
- Indexed
- SCI
SCIE
SSCI
SCOPUS
- Journal Title
- Journal of Affective Disorders
- Volume
- 246
- Start Page
- 157
- End Page
- 165
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/2293
- DOI
- 10.1016/j.jad.2018.12.048
- ISSN
- 0165-0327
1573-2517
- Abstract
- Background
Heart Rate Variability (HRV) parameters have been used to evaluate the autonomic nervous system. We hypothesized that patients with major depressive disorder (MDD) and panic disorder (PD) showed different HRV profiles compared to healthy controls. We also hypothesized that we could predict the responder groups in the MDD and PD patients, using differences in HRV indices between the stress and rest phases.
Methods
28 MDD patients and 29 PD patients were followed for 12 weeks, and we also followed 39 healthy control subjects. We measured HRV parameters at the rest, stress, and recovery phases.
Results
Patients with MDD and PD demonstrated lower pNN50 than controls during the stress (F = 7.49, p = 0.001), and recovery phases (F = 9.43, p = 0.0001). Patients with MDD and PD also showed higher LF/HF ratio than controls during the stress phase (F = 6.15, p = 0.002). Responders in the PD group presented a lower level of LF/HF ratio during the stress phase compared to non-responders (F = 10.14, p = 0.002), while responders in the MDD group showed a lower level of heart rate during all three phases, compared to non-responders. Additionally, we could predict treatment response in patients with MDD using ΔLF/HF ratio (OR: 1.33, 95% CI = 1.07–1.65, p = 0.011) and ΔpNN50 (OR: 1.49, 95% CI 1.09–1.77, p = 0.014).
Conclusion
The changes of HRV parameters of pNN50 and LF/HF ratio between the stress and recovery phase may be clinical markers of predictors of treatment responsiveness in MDD and PD patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Psychiatry > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.